| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000026423 |
| Receipt No. | R000030296 |
| Official scientific title of the study | Prospective study of feasibility and effectivenes of proton beam therapy followed by cryoablation for malignant lung tumors |
| Date of disclosure of the study information | 2017/03/06 |
| Last modified on | 2018/03/06 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Prospective study of feasibility and effectivenes of proton beam therapy followed by cryoablation for malignant lung tumors | |
| Title of the study (Brief title) | Study of feasibility and effectiveness of proton beam therapy followed by cryoablation for lung tumors | |
| Region |
|
|
| Condition | |||
| Condition | Malignant lung tumors | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Feasibility and effectiveness of proton beam therapy followed by cryoablation for malignant lung tumors are examined. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | Complications after treatment. |
| Key secondary outcomes | Local control and overall survival more than 2 years after treatment. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Peripheral primary or metastatic lung tumors larger than 2 cm.
2. Tumors located near lung hilum including less than 2 cm. 3. Tumor local control is not expected by surgery, chemotherapy or conventional radiation therapy. 4. Patients who request cryoablation after radiation therapy, even if tumors could be cured by surgery. 5. Patients who request cryoablation after proton beam therapy rather than cryoablation after stereotactic radiation therapy. 6. Patients with multiple lung metastases whose prognosis could be prolonged by a part of tumors is treated by cryoablation after proton beam therapy. 7. Patients who give informed consent for risk and prognosis after cryoablation after proton beam therapy. |
|||
| Key exclusion criteria | 1. Patients with moderate interstitial pneumonia.
2. Patients who suffered radiation pneumonia after proton beam therapy. 3. Patients with another primary tumors. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Nomori |
| Organization | Kameda Medical Center |
| Division name | General thoracic surgery |
| Address | 929 Higashi-cho Kamogawa City, Chiba, 296-8602 |
| TEL | 0470-92-2211 |
| hnomori@qk9.so-net.ne.jp | |
| Public contact | |
| Name of contact person | Hiroaki Nomori |
| Organization | Kameda Medical Center |
| Division name | General thoracic surgery |
| Address | 929 Higashi-cho Kamogawa City, Chiba, 296-8602 |
| TEL | 0470-92-2211 |
| Homepage URL | |
| hnomori@qk9.so-net.ne.jp | |
| Sponsor | |
| Institute | Kameda Medical Center
General thoracic surgery |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 亀田総合病院(千葉県)
|
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Nothing particulate. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030296 |